These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [A case of transitional cell carcinoma of the urinary bladder with high serum level of CEA and CA19-9].
    Author: Inai H, Shimazui T, Yamamoto T, Yamauchi A, Uchida K, Takeshima H, Akaza H.
    Journal: Hinyokika Kiyo; 2001 Aug; 47(8):583-6. PubMed ID: 11579601.
    Abstract:
    An 85-year-old male with asymptomatic gross hematuria was diagnosed with invasive bladder tumor, transitional cell carcinoma grade 3. Serum levels of CEA and CA19-9 were elevated and histological examination revealed expression of both markers in the cytoplasm of cancer cells. Out of therapeutic options, intra-arterial chemotherapy and radiotherapy were selected because of his age. During the treatment, serum levels of CEA and CA19-9 decreased along with reduction of tumor size. These serum markers have been reported to be elevated in 10 to 60% of patients with bladder tumor and are useful markers for evaluation of the treatment as suggested in the present case.
    [Abstract] [Full Text] [Related] [New Search]